At a Glance
| Detail | Skribe | TrialView |
|---|---|---|
| Category | eDiscovery | eDiscovery |
| Total raised | $9M | $4.1M |
| Rounds tracked | 2 | 1 |
| Latest round | Seed, $5.5M · Mar 2026 | Growth, $4.1M · Nov 2025 |
| Last valuation | Not disclosed | Not disclosed |
| Lead investors | Golden Section | Elkstone Ventures |
| Built for | Large firms, Mid-size firms | Not disclosed |
| Headquarters | United States | Ireland |
Funding, Side by Side
Skribe rounds
- Mar 2026Seed$5.5M
- May 2024Seed$3.5M
TrialView rounds
- Nov 2025Growth$4.1M
Our Take
We have not tested these two head to head yet. The numbers above come from public funding announcements. If you use either one, tell us what you found and it may become a Field Note.
Quick Answers
- Which has raised more, Skribe or TrialView?
- Skribe has raised $9M in disclosed funding, compared with $4.1M for TrialView.
- Do Skribe and TrialView share investors?
- No. None of the investors we track have backed both companies.
- What is Skribe best for?
- Skribe is a digital reporting platform that captures depositions with secure video and human-verified transcripts.
Source: Legal Tech Circle funding data, from public announcements. Updated November 12, 2026.